Advances in Stent Technologies

Table of Contents

1 EXECUTIVE SUMMARY

• Scope and Methodology
  • Scope of the Research Service
  • Methodology
• Stents--Overview and Classification
  • Evolution of Drug Eluting and Bioabsorbable Stents
  • Noteworthy Technological Innovations--A Gist

2 TECHNOLOGY ADOPTION FACTORS

• Technology-Related Drivers and Challenges
  • Drivers for the Technology and the Industry
  • Technology and Industry-Related Challenges
  • Current and Future Trends
• A Basic SWOT Analysis; Analyst Perceptions and Insights
  • DES Technology--A Basic SWOT Analysis
  • Analyst Perceptions and Insights

3 INNOVATIONS IN DES SPACE

• DES Innovations--USA and Canada
  • Successful Launch of Hydroxyapatite-Based Stents--Canada
  • Customizable Biodegradable Stents for Single Long and Multiple Lesions--USA
  • Sirolimus-Based Biodegradable Stents--USA
• DES Innovations--Europe and Other Countries
  • New Hybrid Drug Device Combination to Lower Restenosis Rates--Japan
  • Polymer-Free Matrices to the Rescue of Interventionalists--Germany
  • A Stent Structure with an Unique Design and a Biostable Polymer--Spain
  • Low-Dose Drug Release Kinetics Helps Lower Thrombosis Rates--South Africa
  • Melatonin-Based Drug Eluting Stents--Netherlands
  • Low-Dose Paclitaxel-Based Stent Scores over First Generation DES--Germany

4 PATENT INFORMATION AND KEY CONTACTS

• Patents in US and Europe
  • US and Canada Patents
  • Patents in Europe and Rest of the World
• Key Contacts and Glossary
  • Key Contacts--Industry and Academia
  • Glossary

5 DECISION SUPPORT DATABASE

• Database Tables
  • Total Healthcare Expenditure--World (2002 to 2012)
  • Total Number of Hospitals--World (2002 to 2012)
  • Total Number of Physicians--World (2002 to 2012)
  • Incidence of Myocardial Infarction (Heart Attack) (2002 to 2012)
  • Prevalence of Chronic Obstructive Pulmonary Disease (COPD) (2002 to 2012)